• English
  • தமிழ்
  • বাংলা
  • മലയാളം
  • ગુજરાતી
  • हिंदी
  • मराठी
  • Business

The Financial Express

  • Whatsapp Whatsapp Link
  • Facebook Facebook Link
  • Twitter Twitter Link
  • Linkedin Linkedin Link
Google News Follow
Watchlist
  • Home
  • Business
  • Markets
  • Market Stats
  • Mutual Funds
  • Money
  • India News
  • Tech
  • US News
  • Shorts
  • ePaper
  • Defence Stocks
  • AI Stocks
  • MF Screener
  • Finance Stocks
  • IT Stocks
  • Gold Rate
  • Silver Rate
  • Breakout Stocks
  • Home
  • Market
    • Stock Insights
    • Cryptocurrency
    • IPO News
    • Stock Market Quotes
    • Indices
    • Nifty 50
    • Sensex
    • Top Gainers
    • Top Losers
    • IPO Stats
  • Market Dashboard
  • Commodities
    • Gold Rate in India
    • Silver Rate in India
    • Petrol Rate in India
    • Diesel Rate in India
  • Opportunity Abroad
  • Money
    • Insurance
    • Income Tax
    • Mutual Funds News
    • MF Screener
  • Economy
  • Business
    • Brand Wagon
    • SME
    • Defence
    • Healthcare
  • Industry
    • Banking & Finance
  • India News
  • World News
  • Trending News
  • Jobs-Career
  • Infrastructure
    • Railways
    • Aviation
    • Roadways
  • Auto
  • Life
    • Lifestyle
    • Entertainment
    • Technology
    • Travel & Tourism
    • Science
  • Sports
  • Opinion
  • Multimedia
    • Photos
    • Web Stories
  • Events
  • ePaper
  • Today’s Paper
  • About us
  • PRIVACY POLICY
  • TERMS AND CONDITIONS
  • Contact Us

  1. Business News
  2. About
  3. novo nordisk

Novo Nordisk

  • Click to share on Twitter (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
Vikrant Shrotriya, MD of Novo Nordisk India
‘This is only the beginning of the GLP-1 journey in India’: Vikrant Shrotriya, MD of Novo Nordisk India

Novo Nordisk India MD Vikrant Shrotriya discusses navigating the post-patent semaglutide generic influx, the massive underpenetration of GLP-1 therapies, and…

July 10, 2026 05:30 IST
‘Automation is reshaping, not shrinking talent’ Q&A with John Dawber, VP, GBS Novo Nordisk

Automation and emerging technologies are reshaping the future of work rather than shrinking opportunities, says John Dawber, vice-president & managing…

Updated: June 29, 2026 05:19 IST
Novo Nordisk cuts prices of Wegovy by 48% as competition intensifies in India’s weight-loss drug market

Novo Nordisk cuts prices of Wegovy and Ozempic in India by up to 48% amid rising competition from cheaper semaglutide…

March 31, 2026 22:38 IST
₹1,000 cr to ₹5,000 cr: 3 pharma stocks to watch for India’s GLP-1 explosion by 2030

A ₹1,000 crore market is set to grow 5x to ₹5,000 crore by 2030 as prices drop 40–50% post patent…

March 31, 2026 05:27 IST
Novo Nordisk vs Eli Lilly: Why the ‘king of weight loss’ just lost its crown

Novo Nordisk’s next-gen obesity drug CagriSema failed to match Eli Lilly’s Zepbound in a head-to-head trial, sending shares down 16%…

February 24, 2026 21:47 IST
The $100 billion pill: Why Novo Nordisk’s weight-loss breakthrough Is tanking its stock

Novo Nordisk just warned that sales could fall by 13% in 2026, sending its stock crashing nearly 20%. The culprit?…

February 4, 2026 17:11 IST
Novo Nordisk Rockets 25% in a Month: But Should You Buy the Rally?

Novo Nordisk shares have surged on the back of its groundbreaking oral Wegovy approval, making it the first company to…

January 16, 2026 18:26 IST
Explained: Why Novo Nordisk is offering the Wegovy pill at $149 a month

Novo Nordisk offers Wegovy weight-loss pill in the US at $149 per month for self-pay patients, expanding access to oral…

January 5, 2026 16:32 IST
Novo Nordisk jumped 9% in a single day. Here’s the pill that did it

Novo Nordisk shares surged nearly 9% in a single session after a key regulatory development in the US. The move…

Updated: December 24, 2025 18:59 IST
FDA approves Novo Nordisk’s popular weight-loss drug Wegovy's daily pill version
FDA approves daily pill version of Novo Nordisk’s weight-loss drug Wegovy – How much will it cost?

Novo Nordisk’s US medical lead, Dr Jason Brett, told CNN that the pill is expected to give patients more choices…

December 23, 2025 07:15 IST
Ozempic India launch, Ozempic weight loss drug India, Ozempic for type 2 diabetes, semaglutide India, Novo Nordisk Ozempic India, Ozempic price in India, Ozempic diabetes medication, Ozempic cardiovascular benefits, Ozempic chronic kidney disease benefit, Ozempic side effects, semaglutide weight loss India, Ozempic patent expiry India, Ozempic generic competition, Novo Nordisk India MD Vikrant Shrotriya, Ozempic vs Wegovy, diabetes drugs India, GLP-1 receptor agonist India, weight loss injections India, obesity treatment India, type 2 diabetes treatment India, Ozempic users worldwide, Ozempic supply India, insulin pricing India, Ryzodeg insulin Novo Nordisk, diabetes medicine pricing India, Ozempic misuse concerns, Ozempic doctor prescription India, Ozempic pharmacovigilance, Ozempic demand India
Ozempic pricing explained: Novo Nordisk India Head says, ‘we’ll drive science and stay competitive’

Vikrant Shrotriya, Novo Nordisk India MD responds to questions on future pricing, generics competition post patent expiry in March, Indian-specific…

Updated: January 11, 2026 10:59 IST
Ozempic launch & beyond: Weight-loss matters, say doctors while appetite builds for generics-led price cuts 
Ozempic launch & beyond: Weight-loss matters, say doctors while appetite builds for generics-led price cuts 

The class of GLP-1 agonist medications act by lowering the appetite with applications way beyond diabetes. These medicines will be…

December 13, 2025 07:27 IST
Novo Nordisk launches Ozempic in India
Ozempic launched in India, prices start at Rs 8,800 per month

Danish drugmaker Novo Nordisk has brought its popular weight loss drug Ozempic to India. Check out prices for all doses.

Updated: January 11, 2026 10:39 IST
100 million Indians could be on GLP-1 drugs by 2030: Healthify CEO

” We are doing $1-2 million run rate revenue in the US. We expect the US business to be larger…

Updated: December 3, 2025 22:36 IST
Novo Nordisk stock plunges to a four-year-low. Here is the reason behind the slump

Novo Nordisk shares plunge after semaglutide Alzheimer’s trial fails to meet its main goal, deepening pressure amid competition, leadership shifts…

November 24, 2025 21:08 IST
Layoffs 2025: The job cuts follow similar moves by Oracle, Microsoft, and other companies that have recently let go of thousands of employees.
Novo Nordisk partners Emcure Pharma for weight loss medicine Poviztra in India

This collaboration combines Novo Nordisk’s innovation in GLP-1 therapies with Emcure’s marketing and distribution strengths to improve access to obesity…

November 10, 2025 23:17 IST
Novo Nordisk joins hands with Emcure Pharma to launch Poviztra, a semaglutide-based weight loss drug, in India. (Source: Freepik)
Novo Nordisk partners Emcure Pharma to commercialise weight loss drug Poviztra in India

Novo Nordisk and Emcure Pharma team up to bring Poviztra, a new weight loss injection, to India. Learn more about…

Updated: November 10, 2025 12:55 IST
Layoffs 2025: The job cuts follow similar moves by Oracle, Microsoft, and other companies that have recently let go of thousands of employees.
Ozempic maker Novo Nordisk to lay off 9,000 employees worldwide to save $1.26 bn

Layoffs 2025: The job cuts follow similar moves by Oracle, Microsoft, and other companies that have recently let go of…

Updated: September 10, 2025 13:37 IST
  • Next »

Related News

Defence
Three orders, Rs 1.53 lakh crore: Submarine, missile and corvette deals could reshape India’s defence order pipeline
Landed Cost of Urea Drops 60% as Easing Global Supplies Cushion India's Subsidy Burden
Import prices of urea down 60% since April peak
Mumbai-Santacruz-Chembur-Link-Road
Mumbai’s Santacruz-Chembur Link Road fully opens; motorists may save up to 35 minutes
Shailendra Katyal, VP & MD, Lenovo India
‘India is a real capability hub inside our global operating model’: Shailendra Katyal, VP & MD, Lenovo India
India’s Electric Car Exports Surge 17-Fold to $369 Million in Q1 Driven by European Demand
EV car exports zoom in Q1, Europe key driver
shorts
Import prices of urea down 60% since April peak
Import prices of urea down 60% since April peak
Economy34 min ago

India’s most consumed soil nutrient, urea, has seen a 60% decline in landed cost due to eased global supplies and diversified imports. The Rashtriya Chemicals and Fertilizers has finalized bids for imports of 1.7 million tonnes at a price range of $390/tonne – $393/tonne. The government is reassessing the initial fertiliser subsidy budget due to a price spike caused by the West Asia war.

View all shorts

Trending Topics

defence stocks
Gold rate today
Silver rate today
AI stocks
mutual funds
semiconductor stocks

Top Categories
  • Market
  • India News
  • Stock Insights
  • Money
  • Opportunities Abroad
  • World News
  • Latest News
  • Technology
  • ITR Guide
  • Money Insights
Stock Screeners
  • Stock Screener
  • Break Out Stocks
  • Defence Stocks
  • Consistently Growing Stocks
  • Low Price Blue Chip Stocks
Top NSE/BSE Companies Share Price
  • Tata Motors share price
  • Tata Steel share price
  • State Bank Of India share price
  • HDFC Bank share price
  • Infosys share price
  • ITC share price
  • Wipro share price
  • NTPC share price
  • ongc share price
  • Adani Enterprises share price
  • Adani Ports and Special Economic Zone share price
  • Bharat Petroleum Corporation share price
  • Coal India share price
  • Bajaj Finance share price
  • ICICI Bank share price
  • Titan Company share price
  • Larsen & Toubro share price
  • Power Grid Corporation Of India share price
  • Asian Paints share price
Gold Price in Top Metro Cities
  • Gold Rate Today
  • Gold Rate in Dubai
  • Gold Rate in Chennai
  • Gold Rate in Kerala
  • Gold Rate in Hyderabad
  • Gold Rate in Bangalore
  • Gold Rate in Mumbai
  • Gold Rate in Noida
  • Gold Price in Delhi
  • Gold Price in Ahmedabad
  • Gold Price in Kolkata
Latest News
  • EV car exports zoom in Q1, Europe key driver
  • Marine exports to get a boost as EU gives nod to more units
  • IPO-bound Muthoot Fincorp reports four-fold jump in Q1 profit to Rs 705 crore 
  • Developers expanding senior living portfolio
  • IBBI flags misuse of insolvency process; asks IPs to step up scrutiny
Follow Us
  • Facebook Facebook Link
  • Twitter Twitter Link
  • Linkedin Linkedin Link
Download Apps
  • Play_stor Play_stor Link
  • Apple_stor Apple_stor Link
Indian Express Group
  • INDIAN EXPRESS GROUP
  • The Indian Express
  • Loksatta
  • Jansatta
  • Inuth
  • Ramnath Goenka Awards
  • IE Tamil
  • IE Malayalam
  • IE Bangla
  • IE Gujarati
  • This website follows the DNPA’s code of conduct
Quick Links
  • T&C
  • Privacy Policy
  • CONTACT US
  • About Us
Copyright © 2026 The Indian Express [P] Ltd. All Rights Reserved
Market Pulse